JUL-AUG 2018

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link:

Contents of this Issue


Page 62 of 68

60 JULY/AUGUST 2018 | Med Esthetics ASAPS ELECTS NEW OFFICERS Grant Stevens, MD, FACS, plastic surgeon, founder and medical director of Marina Plas- tic Surgery and Orange Twist Institute in Marina Del Rey, California, and founder of the Orange Twist Brands, a multi- location chain for noninvasive and minimally invasive aesthetic treatments, is the new presi- dent of the American Society for Aesthetic Plastic Surgery (ASAPS). Dr. Stevens has been an ASAPS member for 24 years, serving on multiple committees including the Executive Com- mittee, Aesthetic Training Committee, Confl ict of Interest Committee, External Marketing Committee, Finance and Investment Committee, Industry Exhibits Committee, Industry Support Committee and the Women Aesthetic Surgeons Committee. He is also chair of the USC Aesthetic Surgery Fel- lowship and director of the USC Division of Aesthetic Surgery. Other newly elected offi cers include: Vice President: Charles H. Thorne, MD, of New York City Vice President: Herluf G. Lund Jr., MD, of St. Louis, Missouri Treasurer: William P. Adams, Jr., MD, of Dallas Secretary: Jennifer L. Walden, MD, of Austin, Texas President of The Aesthetic Surgery Education and Research Foundation (ASERF): Julio Garcia, MD, of Las Vegas REVANCE GEARS UP FOR LAUNCH OF RT002 Revance Therapeutics has established four new positions at the company as it prepares for the launch and commercial- ization of its daxibotulinumtoxinA injectable (RT002) for the treatment of glabellar lines. Dustin Sjuts has been appointed vice president of strategy and sales, aesthetic and therapeutic; Ben Putman is vice president of digital; and Marc Korenberg is senior director of commercial operations. In addition, Erica Bazerkanian has been promoted to vice president of market- ing, aesthetics and therapeutics. All four will report to Todd Zavodnick, chief commercial offi cer and president of aesthet- ics & therapeutics. Sjuts, who previously worked with Nestle Skin Health, Alphaeon and Allergan, will head all product sales activities, championing strategies to enhance physician relations and drive new product adoption. Putman, who previously served as senior vice president, general manager and senior vice president of creative technol- ogy and innovation at JUICE Pharma Advertising, will lead digital marketing and strategy activities. Allergan and Zeltiq Aesthetics alumni Korenberg will manage commercial operations activities at Revance, including customer excellence and relationship management, commercial analytics, commercial programs and commercial fi nancial management. Bazerkanian will be responsible for strategic marketing, launch planning, product development and public relations. Prior to this position, she served as head of strategic marketing at Revance and senior director of marketing at Kythera Biopharmaceuticals. "Revance continues to attract accomplished talent in the industry, and we are pleased to announce the addition of these seasoned leaders to our commercial team," said Zavodnick. "Each of these individuals possesses a proven track record and will play an important role as we implement the Revance Prod- uct Launch Velocity Plan for the successful commercialization of Revance's lead product candidate RT002 and expand our presence in both aesthetics and therapeutic medicine." HARTMAN NAMED CCO OF ALASTIN ALASTIN Skincare has appointed James P. Hart- man to the position of chief commercial offi cer. Hartman most recently served as vice president and general manager at Solta Medical, a division of Valeant Pharmaceuticals. Prior to Solta, he was VP and U.S. head of aesthetics & OTC at Merz Aesthetics and VP of global marketing and business development at Obagi Medical. "We are extremely pleased to have Jim join ALASTIN as a key member of the executive team to lead our commercialization activities as we continue the rapid growth of our current prod- ucts and build our product pipeline," said Diane S. Goostree, president and CEO of ALASTIN Skincare. "Jim's extensive operating background in the medical aesthetics space, includ- ing experience with energy-based rejuvenating devices, is a natural fi t for us as we develop and launch new products and expand our sales force." CRESCITA ANNOUNCES NEW TEAM MEMBERS Crescita Therapeutics, a commercial dermatology company with a portfolio of nonprescription skincare products and pre- scription drug products, has announced the appointment of two former members of the Valeant leadership team to its ranks. Serge Verreault, current president of Crescita, is now president and CEO of the company. Verreault worked at Valeant Canada for 14 years in a variety of positions, including executive director NEWS & EVENTS James P. Hartman Grant Stevens, MD, FACS

Articles in this issue

Archives of this issue

view archives of Medesthetics - JUL-AUG 2018